Gyre Therapeutics (GYRE) Loans and Notes Receivables: 2022-2025
Historic Loans and Notes Receivables for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $693,000.
- Gyre Therapeutics' Loans and Notes Receivables rose 661.54% to $693,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $693,000, marking a year-over-year increase of 661.54%. This contributed to the annual value of $4.4 million for FY2024, which is 1024.16% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Loans and Notes Receivables is $693,000, which was up 38.88% from $499,000 recorded in Q2 2025.
- Gyre Therapeutics' 5-year Loans and Notes Receivables high stood at $4.4 million for Q4 2024, and its period low was $91,000 during Q3 2024.
- In the last 3 years, Gyre Therapeutics' Loans and Notes Receivables had a median value of $444,000 in 2023 and averaged $1.1 million.
- In the last 5 years, Gyre Therapeutics' Loans and Notes Receivables crashed by 74.44% in 2023 and then surged by 1,024.16% in 2024.
- Quarterly analysis of 4 years shows Gyre Therapeutics' Loans and Notes Receivables stood at $1.5 million in 2022, then plummeted by 74.44% to $389,000 in 2023, then soared by 1,024.16% to $4.4 million in 2024, then spiked by 661.54% to $693,000 in 2025.
- Its Loans and Notes Receivables was $693,000 in Q3 2025, compared to $499,000 in Q2 2025 and $2.1 million in Q1 2025.